ClinConnect ClinConnect Logo
Search / Trial NCT06125093

Study of an Early Parenting Intervention for Children With Genetic Abnormalities and Mental Health Problems

Launched by FUNDACIÓ SANT JOAN DE DÉU · Nov 3, 2023

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Early Intervention Parenting Randomized Controlled Trial Pragmatic Genetic Syndromes Mental Health Development

ClinConnect Summary

The GAP study is a clinical trial designed to help families with young children who have genetic abnormalities and mental health challenges, such as language delays or social difficulties. The trial is testing a program called "Incredible Years Autism Spectrum and Language Delays" (IY-ASLD®), which will be delivered online through 22 weekly group sessions. Families will be randomly chosen to either participate in this new program or continue with their usual care. The goal is to see how well the program works and if it can provide better support for these children and their families.

To participate, children must be between 3 and 7 years old, have a possible genetic condition, and show signs of social challenges or developmental problems. Parents or caregivers should understand Spanish or Catalan and agree to join the study. It's important to note that children already diagnosed with Autism Spectrum Disorder or attending another parenting program cannot participate. This study aims to gather valuable information that can help doctors and policymakers provide better treatment options for these vulnerable children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Children aged 3.0 - 7.11 years at recruitment
  • 2. Children with a diagnosis or in diagnostic process for high suspicion of a genetic abnormality
  • 3. For children up to 5.11 years with withdrawn (defined as CBCL/1.5-5 scores above the borderline clinical range, T-score\> 65) AND/OR pervasive developmental problems (defined as CBCL/1.5-5 scores above the borderline clinical range, T-score\> 65) AND/OR socialization difficulties (defined as Vineland-III scores below 1SD in the socialization subdomains).
  • 4. For children over 6 years with social problems (defined as CBCL/6-18 scores above the borderline clinical range, T-score\> 65) AND/OR thought problems (defined as CBCL/6-18 scores above the borderline clinical range, T-score\> 65) AND/OR socialization difficulties (defined as Vineland-III scores below 1SD in the socialization subdomains).
  • 5. Parents/caregivers showing good understanding of the Spanish or Catalan language
  • 6. Parents/caregivers consenting to take part in the study and signing the informed consent
  • Exclusion Criteria:
  • 1. Children diagnosed with an Autism Spectrum Disorder
  • 2. Children scoring above diagnostic cut-off for Autism or Autism Spectrum Disorder in the ADOS-2.
  • 3. Attending another structured parenting program
  • 4. Children in the care of their local authority

About Fundació Sant Joan De Déu

Fundació Sant Joan de Déu is a distinguished clinical trial sponsor dedicated to advancing medical research and improving patient care. Affiliated with the renowned Sant Joan de Déu Hospital in Barcelona, the foundation focuses on innovative healthcare solutions, fostering collaboration among healthcare professionals, researchers, and institutions. With a commitment to ethical practices and patient-centered approaches, Fundació Sant Joan de Déu supports a diverse range of clinical studies aimed at addressing complex health challenges and enhancing therapeutic outcomes. Through its comprehensive research programs, the foundation strives to contribute significantly to the field of medicine and the well-being of communities.

Locations

Barcelona, , Spain

Sabadell, , Spain

Esplugues De Llobregat, Barcelona, Spain

Patients applied

0 patients applied

Trial Officials

Laia Villalta, MD, PhD

Principal Investigator

Hospital Sant Joan de Déu. Fundació Privada per a la Recerca i la Docència Sant Joan de Déu

Anna Maria Cueto-González, MD

Study Chair

Hospital Universitari Vall d'Hebron. Vall d'Hebron Institut de Recerca

Carmen Manso, MD

Study Chair

Parc Taulí Hospital Universitari

Mercedes Serrano, MD, PhD

Study Chair

Hospital Sant Joan de Deu

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported